EVP R&D, Chief Medical Officer
Fri, May 1, 2026
May 1
5,000 shares @ $19.34
Increased holdings by +5.90%
62nd largest trade (out of 152)
Trade made by an officer
10b5-1 scheduled trade
38% win rate · -4.7% median edge vs SPY (24 trades, 90-day)
Insider trade was 42% below market price
Price 11% above 200-day moving average